Immuron (Warrant)

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch IMRNW and buy or sell other stocks, ETFs, and their options commission-free!

About IMRNW

Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. It operates through the Hyper-immune Products and Research and Development (R&D) segments. 

CEO
Steven Lydeamore, MBA
CEOSteven Lydeamore, MBA
Employees
—
Employees—
Headquarters
Blackburn, Victoria (VIC)
HeadquartersBlackburn, Victoria (VIC)
Founded
1994
Founded1994
Employees
—
Employees—

IMRNW Key Statistics

Market cap
—
Market cap—
Price-Earnings ratio
—
Price-Earnings ratio—
Dividend yield
—
Dividend yield—
Average volume
—
Average volume—
High today
—
High today—
Low today
—
Low today—
Open price
—
Open price—
Volume
0.00
Volume0.00
52 Week high
—
52 Week high—
52 Week low
—
52 Week low—

IMRNW News

TipRanks 13h
Immuron Publishes CEO Address and Annual General Meeting Results

An announcement from Immuron ( (IMRN) ) is now available. On November 18, 2026, Immuron published ASX announcements titled “CEO Address” and “Results of Annual...

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.